Dutch drugs association wants clear, predictable reimbursement procedures from pharma package [Advocacy Lab Content] on 28/05/24
The Dutch innovative medicines association, VIG, says amendments to the pharmaceutical legislation adopted by the European Parliament aren't enough to ease concerns. EU determined to push forward with Pandemic Treaty negotiations despite setbacks on 27/05/24
Despite an additional week of intensive talks, negotiators were unable to reach agreement on the text of a new Pandemic Accord ahead of the World Health Assembly. I want to empower patients, says Green group’s health expert on 23/05/24
“What kind of europe do we want? A Europe that puts patients’ needs at the forefront, or that prioritises the interests of big pharma?” says Greens health expert Tilly Metz Commission boasts EU’s health achievements as more work beckons on 23/05/24
‘The European Health Union: Acting together for people’s health’ is how the Commission summed up its last five years of actions in health. The EU went "from firefighter to architect", in the words of Commission Vice President Margaritis Schinas, but not everyone is convinced the current architecture is optimal. Beating cancer in Europe: A health priority within our grasp [Promoted content] on 22/05/24
Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation. European Health Union: ‘L’Union fait la force’ on 22/05/24
The European Commission will present its update of the ‘European Health Union: a Europe that prepares, prevents and protects' on Wednesday (22 May). Like the Belgian motto, ‘L’Union fait la force’ [Unity makes strength], the Health Union's aim is to create a more resilient Europe. Poland’s medical innovation advances despite ongoing challenges, report shows [Advocacy Lab Content] on 21/05/24
Polish medical innovation has seen improvements, yet significant challenges remain, according to the latest Access GAP data, with access to innovative therapies and diagnostics increasing. Czech clinical trials lead with 40% increase in cancer drug studies [Advocacy Lab Content] on 21/05/24
In Czechia, new data shows over 16,000 patients have been included in the research efforts for new drugs and vaccines, with clinical trials most frequently focusing on oncology and immunology. Swedish neurologists warn ALS patients may have to self-pay for new gene therapy [Advocacy Lab Content] on 21/05/24
Swedish doctors fear Swedish patients may have to pay out-of-pocket for a treatment that targets a genetic cause of the neurodegenerative disease ALS. European authorities will decide this spring whether the drug can be marketed in Europe. Pharma industry fears Bulgarian political crisis could hurt negotiations [Advocacy Lab Content] on 21/05/24
The Bulgarian pharmaceutical industry fears that the country's political crisis could negatively impact the protection of national interests during the negotiations on the new European pharmaceutical legislation.
|
|
